Solidago canadensis L. Herb Extract, Its Amino Acids Preparations and 3D-Printed Dosage Forms: Phytochemical, Technological, Molecular Docking and Pharmacological Research

<b>Background/Objectives</b>: The Canadian goldenrod (<i>Solidago canadensis</i> L.) is one of the most widespread species of the genus <i>Solidago</i> from the Asteraceae family. It has a rich composition of biologically active compounds and is traditionally used to address kidney, urinary tract, and liver diseases. Previously, it was proven that the <i>S. canadensis</i> extract obtained with a 40% ethanol solution had the most promising anti-inflammatory and hepatoprotective activity. Therefore, this extract was selected for the further formulation of amino acid preparations and 3D-printed dosage forms. The aims of the present study were to investigate the chemical composition, toxicity, and antimicrobial, anti-inflammatory, and hepatoprotective activity of <i>S. canadensis</i> dry extract, its amino acid preparations, and 3D-printed dosage forms. <b>Results</b>: A total of 18 phenolic compounds and 14 amino acids were determined in the extracts. The <i>S. canadensis</i> herb extracts were verified to be practically non-toxic preparations (toxicity class V, LD₅₀ > 5000 mg/kg). They also showed moderate antimicrobial activity against <i>Staphylococcus aureus</i>, <i>Enterococcus faecalis,</i> and β-hemolytic <i>Streptococcus pyogenes</i>. The most pronounced hepatoprotective activity was observed with <i>S. canadensis</i> herb extract and its amino acid preparations with phenylalanine, alanine, and lysine at a dose of 25 mg/kg body weight. The most pronounced anti-inflammatory activity was found with <i>S. canadensis</i> herb extract and its preparation with arginine. According to the calculated docking score array and the analysis of binding modes in the active sites of COX-1 and COX-2, the flavonoid fraction and caffeic acid in the <i>S. canadensis</i> extracts presented moderate inhibitory activity. <b>Conclusions</b>: The development of innovative 3D-printed oral dosage forms represents a promising strategy to formulate dietary supplements or pharmaceutical preparations for these herbal extracts.

Authors

Institutions

Publication Details

Journal
Pharmaceutics
Published
2025-03-24
DOI
https://doi.org/10.3390/pharmaceutics17040407
Citations
4
Primary Topic
Drug-Induced Hepatotoxicity and Protection
Type
article
Field-Weighted Citation Impact
6.23

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Solidago canadensis L. Herb Extract, Its Amino Acids Preparations and 3D-Printed Dosage Forms: Phytochemical, Technological, Molecular Docking and Pharmacological Research

Yurii Hrytsyk, Lyubov Grytsyk, Jyrki Heinämäki, Aіn Raal et al.
4 citations
Pharmaceutics
Drug-Induced Hepatotoxicity and Protection
6.23
article

Solidago canadensis L. Herb Extract, Its Amino Acids Preparations and 3D-Printed Dosage Forms: Phytochemical, Technological, Molecular Docking and Pharmacological Research

Yurii Hrytsyk, Lyubov Grytsyk, Jyrki Heinämäki, Aіn Raal, Мarharyta Suleiman, Lina Perekhoda, Valdas Jakštas, Vaidotas Žvikas, Oleh Коshovyi, O. І. Yurchyshyn
article en
4 citations

Abstract

<b>Background/Objectives</b>: The Canadian goldenrod (<i>Solidago canadensis</i> L.) is one of the most widespread species of the genus <i>Solidago</i> from the Asteraceae family. It has a rich composition of biologically active compounds and is traditionally used to address kidney, urinary tract, and liver diseases. Previously, it was proven that the <i>S. canadensis</i> extract obtained with a 40% ethanol solution had the most promising anti-inflammatory and hepatoprotective activity. Therefore, this extract was selected for the further formulation of amino acid preparations and 3D-printed dosage forms. The aims of the present study were to investigate the chemical composition, toxicity, and antimicrobial, anti-inflammatory, and hepatoprotective activity of <i>S. canadensis</i> dry extract, its amino acid preparations, and 3D-printed dosage forms. <b>Results</b>: A total of 18 phenolic compounds and 14 amino acids were determined in the extracts. The <i>S. canadensis</i> herb extracts were verified to be practically non-toxic preparations (toxicity class V, LD₅₀ > 5000 mg/kg). They also showed moderate antimicrobial activity against <i>Staphylococcus aureus</i>, <i>Enterococcus faecalis,</i> and β-hemolytic <i>Streptococcus pyogenes</i>. The most pronounced hepatoprotective activity was observed with <i>S. canadensis</i> herb extract and its amino acid preparations with phenylalanine, alanine, and lysine at a dose of 25 mg/kg body weight. The most pronounced anti-inflammatory activity was found with <i>S. canadensis</i> herb extract and its preparation with arginine. According to the calculated docking score array and the analysis of binding modes in the active sites of COX-1 and COX-2, the flavonoid fraction and caffeic acid in the <i>S. canadensis</i> extracts presented moderate inhibitory activity. <b>Conclusions</b>: The development of innovative 3D-printed oral dosage forms represents a promising strategy to formulate dietary supplements or pharmaceutical preparations for these herbal extracts.

PharmaceuticsVol. 17(4)
Lithuanian University of Health Sciences (LT), Ivano-Frankivsk National Medical University (UA), National University of Pharmacy (UA), University of Tartu (EE)
European Commission, Eesti Teadusagentuur, NordForsk
Openalex Percentile: Top 4%
Drug-Induced Hepatotoxicity and Protection
6.23
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.